OncoMark profiled in 'Ones to Watch' article in Business & Finance
The need for the OncoMasTR assay to determine which patients require chemotherapy was discussed, along with the funding awarded to OncoMark by the European Commission for product development. OncoMark, a Dublin-based company, plan to expand over the next two-three years, as the product development progresses. The OncoMasTR assay is expected to be available for clinical use in the next three years.
The article can be viewed here: